Hannah R. Robinson

1.6k total citations
17 papers, 410 citations indexed

About

Hannah R. Robinson is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Epidemiology. According to data from OpenAlex, Hannah R. Robinson has authored 17 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Epidemiology. Recurrent topics in Hannah R. Robinson's work include Monoclonal and Polyclonal Antibodies Research (6 papers), HIV Research and Treatment (3 papers) and Pneumonia and Respiratory Infections (3 papers). Hannah R. Robinson is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), HIV Research and Treatment (3 papers) and Pneumonia and Respiratory Infections (3 papers). Hannah R. Robinson collaborates with scholars based in United States, United Kingdom and Italy. Hannah R. Robinson's co-authors include Matthew D. Snape, Daniela Toneatto, Andrew J. Pollard, Tessa M. John, Amy W. Chung, Sarah Kelly, Galit Alter, Peter Dull, Max Crispin and Chris Scanlan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Hannah R. Robinson

16 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hannah R. Robinson United States 8 128 119 112 93 87 17 410
O Asai Japan 11 436 3.4× 74 0.6× 119 1.1× 117 1.3× 42 0.5× 17 726
Ann‐Marie Lobo United States 9 64 0.5× 129 1.1× 28 0.3× 74 0.8× 61 0.7× 23 526
Britt Thuresson Sweden 12 82 0.6× 48 0.4× 26 0.2× 102 1.1× 20 0.2× 23 412
Anders Waage Norway 8 164 1.3× 74 0.6× 67 0.6× 105 1.1× 14 0.2× 10 379
Victoria Martin United Kingdom 7 402 3.1× 77 0.6× 10 0.1× 118 1.3× 161 1.9× 7 542
Yukitsugu Nakamura Japan 8 159 1.2× 130 1.1× 119 1.1× 109 1.2× 12 0.1× 19 389
Anne‐Laure Puaux France 8 289 2.3× 44 0.4× 7 0.1× 108 1.2× 42 0.5× 12 421
Kenichi Ogasawara Japan 17 60 0.5× 90 0.8× 23 0.2× 140 1.5× 24 0.3× 61 1.0k
Hitoshi Hanamoto Japan 9 249 1.9× 21 0.2× 12 0.1× 68 0.7× 16 0.2× 29 422
B A Fernie United Kingdom 14 402 3.1× 54 0.5× 146 1.3× 73 0.8× 48 0.6× 26 456

Countries citing papers authored by Hannah R. Robinson

Since Specialization
Citations

This map shows the geographic impact of Hannah R. Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannah R. Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannah R. Robinson more than expected).

Fields of papers citing papers by Hannah R. Robinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hannah R. Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannah R. Robinson. The network helps show where Hannah R. Robinson may publish in the future.

Co-authorship network of co-authors of Hannah R. Robinson

This figure shows the co-authorship network connecting the top 25 collaborators of Hannah R. Robinson. A scholar is included among the top collaborators of Hannah R. Robinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hannah R. Robinson. Hannah R. Robinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Robinson, Hannah R., S. Lindsey Davis, Christopher H. Lieu, et al.. (2025). Molecular and clinical profiling of gastroenteropancreatic (GEP) neuroendocrine tumors (NETs): An analysis of the Oncology Research Information Exchange Network database.. Journal of Clinical Oncology. 43(4_suppl). 669–669.
2.
Robinson, Hannah R., Wells A. Messersmith, & Robert W. Lentz. (2024). HER2-Positive Metastatic Colorectal Cancer. Current Treatment Options in Oncology. 25(5). 585–604. 7 indexed citations
3.
Lentz, Robert W., Patrick J. Blatchford, Kimberly R. Jordan, et al.. (2024). A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer. Clinical Cancer Research. 30(17). 3768–3778. 4 indexed citations
4.
Lentz, Robert W., Patrick J. Blatchford, Junxiao Hu, et al.. (2024). Results of a phase 2 study of evorpacept (E, ALX148), cetuximab (C), and pembrolizumab (P) in patients with refractory microsatellite stable metastatic colorectal cancer (MSS CRC).. Journal of Clinical Oncology. 42(16_suppl). 3530–3530. 1 indexed citations
5.
Robinson, Hannah R., Laura Graham, Philippe E. Spiess, et al.. (2024). Comprehensive genomic profiling (CGP) of squamous cell carcinoma of unknown primary (SCCUP) presenting with inguinal, pelvic, and retroperitoneal (I/P/RP) metastases.. Journal of Clinical Oncology. 42(4_suppl). 7–7. 1 indexed citations
6.
Robinson, Hannah R., et al.. (2021). Targeting MET Amplification with Crizotinib in a Case of Sinonasal Undifferentiated Carcinoma. Cancer Investigation. 39(3). 235–239. 2 indexed citations
7.
Chung, Amy W., Jenniffer M. Mabuka, Anna F. Licht, et al.. (2018). Viral control in chronic HIV-1 subtype C infection is associated with enrichment of p24 IgG1 with Fc effector activity. AIDS. 32(10). 1207–1217. 19 indexed citations
8.
Robinson, Hannah R., Junpeng Qi, Erika M. Cook, et al.. (2018). A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era. Blood. 132(5). 521–532. 89 indexed citations
9.
Robinson, Hannah R., Junpeng Qi, Sivasubramanian Baskar, et al.. (2017). Activity of CD19/CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia. Blood. 130(Suppl_1). 799–799. 2 indexed citations
10.
Snape, Matthew D., Tessa M. John, Sarah Kelly, et al.. (2015). Persistence of specific bactericidal antibodies at 5 years of age after vaccination against serogroup B meningococcus in infancy and at 40 months. Canadian Medical Association Journal. 187(7). E215–E223. 24 indexed citations
11.
Chung, Amy W., Matthew K. Schoen, Hannah R. Robinson, et al.. (2014). Polyfunctional Non-neutralizing Fc-antibody Responses in Acute HIV Infection Predict Spontaneous Viral Control. AIDS Research and Human Retroviruses. 30(S1). A89–A89. 1 indexed citations
12.
Snape, Matthew D., Tessa M. John, Sarah Kelly, et al.. (2014). Persistence of Bactericidal Antibodies to 5 Years of Age After Immunization With Serogroup B Meningococcal Vaccines at 6, 8, 12 and 40 Months of Age. The Pediatric Infectious Disease Journal. 33(7). 760–766. 30 indexed citations
13.
Chung, Amy W., Max Crispin, Laura K. Pritchard, et al.. (2014). Identification of antibody glycosylation structures that predict monoclonal antibody Fc-effector function. AIDS. 28(17). 2523–2530. 98 indexed citations
14.
Snape, Matthew D., Tessa M. John, Hannah R. Robinson, et al.. (2013). Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose. Canadian Medical Association Journal. 185(15). E715–E724. 61 indexed citations
15.
Chung, Amy W., Hannah R. Robinson, Josephine H. Cox, et al.. (2012). Vector induced skewing of antibody Fc-effector functions. Retrovirology. 9(S2). 1 indexed citations
16.
Bernhardt, Ingolf, et al.. (2007). Differential Effect of HOE642 on Two Separate Monovalent Cation Transporters in the Human Red Cell Membrane. Cellular Physiology and Biochemistry. 20(5). 601–606. 46 indexed citations
17.
Browning, Joseph, Hannah R. Robinson, Clive Ellory, & John S. Gibson. (2007). Deoxygenation-Induced Non-Electrolyte Pathway in Red Cells from Sickle Cell Patients. Cellular Physiology and Biochemistry. 19(1-4). 165–174. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by O Asai Breakdown of academic impact, for papers by Ann‐Marie Lobo Breakdown of academic impact, for papers by Britt Thuresson Breakdown of academic impact, for papers by Anders Waage Breakdown of academic impact, for papers by Victoria Martin Breakdown of academic impact, for papers by Yukitsugu Nakamura Breakdown of academic impact, for papers by Anne‐Laure Puaux Breakdown of academic impact, for papers by Kenichi Ogasawara Breakdown of academic impact, for papers by Hitoshi Hanamoto Breakdown of academic impact, for papers by B A Fernie
Rankless by CCL
2026